Global Heparin Sodium Market Projected to Grow at a CAGR of 6.7% by 2034 According to a newly published market research report by 24LifeSciences, global Heparin Sodium market was valued at USD 2.68 billion in 2026 and is projected to reach USD 4.06 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period. Heparin Sodium, derived primarily from porcine intestinal mucosa, is a naturally occurring anticoagulant and a cornerstone therapy for preventing and treating life-threatening thrombotic disorders such as deep vein thrombosis (DVT), pulmonary embolism (PE), and acute coronary syndromes. It functions by potentiating antithrombin III to inactivate key clotting factors, thereby preventing the formation and extension of dangerous blood clots. Its well-established efficacy and immediate onset of action continue to make it indispensable in surgical procedures, dialysis, and critical care settings worldwide. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7436/heparin-sodium-market

Surgical Hemostats Market Forecast to Reach USD 1.63 Billion by 2032 on Surging Procedure Volumes Surgical Hemostats Market, valued at USD 942.15 million in 2024, is projected to grow from USD 1.01 billion in 2025 to USD 1.63 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.2% during the forecast period. This significant growth is driven by an increasing global volume of surgical procedures, spurred by an aging population and rising prevalence of chronic conditions. The expanding adoption of minimally invasive surgeries and ongoing technological advancements in hemostatic agents are further propelling the market forward. Explore the complete global market forecast and competitive landscape analysis in the full research study. https://www.24chemicalresearch.com/reports/258487/global-surgical-hemostats-market-2024-878